You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
  1. CORPORATE - 31-10-2017

    Kedrion and Cerus enter distribution agreement for INTERCEPT in Italy

    Agreement covers complete INTERCEPT product line: platelets, plasma and red blood cells

    read more 
  2. CORPORATE - 25-08-2017

    Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®

    The product is approved for post-exposure prophylaxis against rabies infection

    read more 
  3. EVENTS - 14-07-2017

    Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany

    A crowded symposium dedicated to the SIPPET Study was held on July 9th

    read more 
  4. EVENTS - 22-05-2017

    Farmindustria roadshow is hosted by Kedrion

    Innovation and Production of Value held on 19th May at our Bolognana production plant

    read more 

Pages

For more information please contact: pressoffice@kedrion.com